{"organizations": [], "uuid": "f2320203e62d175f6a821c98e4e7593a32818676", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180227.html", "section_title": "Archive News &amp; Video for Tuesday, 27 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-depomed-reports-q4-gaap-loss-per-s/brief-depomed-reports-q4-gaap-loss-per-share-0-52-idUSASB0C7SJ", "country": "US", "domain_rank": 408, "title": "BRIEF-Depomed Reports Q4 GAAP Loss Per Share $0.52", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.131, "site_type": "news", "published": "2018-02-28T05:14:00.000+02:00", "replies_count": 0, "uuid": "f2320203e62d175f6a821c98e4e7593a32818676"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-depomed-reports-q4-gaap-loss-per-s/brief-depomed-reports-q4-gaap-loss-per-share-0-52-idUSASB0C7SJ", "ord_in_thread": 0, "title": "BRIEF-Depomed Reports Q4 GAAP Loss Per Share $0.52", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 27 (Reuters) - Depomed:\n* ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS\n* Q4 GAAP LOSS PER SHARE $0.52 * Q4 REVENUE $94 MILLION * INC - ‍Q4 2017 ENDING CASH AND MARKETABLE SECURITIES WERE $128 MILLION​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-28T05:14:00.000+02:00", "crawled": "2018-02-28T13:16:17.018+02:00", "highlightTitle": ""}